
0:19
Short YouTube health-advice clip where the speaker (Dr. Charles Mok) contrasts tirzepatide with semaglutide, noting a less expensive compounded form, and emphasizes that medication should be paired with lifestyle-based weight-loss efforts so patients may eventually stop the drug (possibly aided by metformin).










